ATE458496T1 - Hiv-vakzine und anwendungsverfahren - Google Patents
Hiv-vakzine und anwendungsverfahrenInfo
- Publication number
- ATE458496T1 ATE458496T1 AT03729676T AT03729676T ATE458496T1 AT E458496 T1 ATE458496 T1 AT E458496T1 AT 03729676 T AT03729676 T AT 03729676T AT 03729676 T AT03729676 T AT 03729676T AT E458496 T1 ATE458496 T1 AT E458496T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- application
- hiv vaccines
- pharmaceutical compositions
- hiv
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Gynecology & Obstetrics (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US34869502P | 2002-01-14 | 2002-01-14 | |
PCT/US2003/001261 WO2003059385A2 (en) | 2002-01-14 | 2003-01-14 | Hiv vaccine and method of use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE458496T1 true ATE458496T1 (de) | 2010-03-15 |
Family
ID=23369136
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03729676T ATE458496T1 (de) | 2002-01-14 | 2003-01-14 | Hiv-vakzine und anwendungsverfahren |
Country Status (8)
Country | Link |
---|---|
US (3) | US20050175631A1 (de) |
EP (1) | EP1471936B1 (de) |
AT (1) | ATE458496T1 (de) |
CA (1) | CA2472579A1 (de) |
DE (1) | DE60331412D1 (de) |
DK (1) | DK1471936T3 (de) |
ES (1) | ES2339762T3 (de) |
WO (1) | WO2003059385A2 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1977971A (zh) * | 2001-06-07 | 2007-06-13 | 惠氏控股有限公司 | 作为佐剂的霍乱全毒素的突变体形式 |
BR0210216A (pt) * | 2001-06-07 | 2004-06-08 | Wyeth Corp | Holotoxina do cólera imunogênica, mutante (ct-crm), composição imunogênica, métodos para aumentar a resposta imune de um hospedeiro vertebrado a um antìgeno, e para produzir uma holotoxina do cólera imunogênica, mutante, sequência ou molécula de ácido nucleico isolado e purificado, célula hospedeira, e, uso de uma holotoxina do cólera mutante |
GB0302218D0 (en) * | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
US20060147466A1 (en) * | 2002-05-14 | 2006-07-06 | Chiron Srl | Mucosal combination vaccines for bacterial meningitis |
CA2539021A1 (en) * | 2003-09-15 | 2005-03-31 | Chiron Corporation | Combination approaches for generating immune responses |
CA2626253A1 (en) * | 2005-10-18 | 2007-04-26 | Novartis Vaccines And Diagnostics, Inc. | Mucosal and systemic immunizations with alphavirus replicon particles |
EP2019686B1 (de) | 2006-03-31 | 2012-07-11 | Novartis AG | Kombinierte mukosale und parenterale immunisierung gegen hiv |
CN102123724B (zh) | 2008-06-19 | 2018-05-01 | 变异生技公司 | 治疗流行性感冒的组合物和方法 |
WO2011005772A1 (en) | 2009-07-06 | 2011-01-13 | Variation Biotechnologies, Inc. | Methods for preparing vesicles and formulations produced therefrom |
JP5854559B2 (ja) | 2009-07-06 | 2016-02-09 | ヴァリエーション バイオテクノロジーズ インコーポレイテッド | 小胞を調製する方法及びこれから製造される製剤 |
WO2012023008A2 (en) * | 2010-05-03 | 2012-02-23 | Dcb-Usa Llc | Polysaccharide conjugation with detoxified e. coli heat labile enterotoxin (lt) used as vaccine |
EP2590674B1 (de) | 2010-07-06 | 2017-02-22 | Variation Biotechnologies Inc. | Zusammensetzungen und verfahren zur influenza-behandlung |
US10736844B2 (en) | 2011-01-13 | 2020-08-11 | Variation Biotechnologies Inc. | Compositions and methods for treating viral infections |
EP2802353A4 (de) | 2012-01-12 | 2015-12-02 | Variation Biotechnologies Inc | Zusammensetzungen und verfahren zur behandlung von virusinfektionen |
AU2013213345A1 (en) | 2012-01-27 | 2014-08-28 | Variation Biotechnologies, Inc. | Methods and compositions for therapeutic agents |
US11709163B2 (en) | 2014-10-08 | 2023-07-25 | Avioq, Inc. | Methods for simultaneous determination of serological profile and estimation of duration post HIV infection |
CN108367058A (zh) * | 2015-11-10 | 2018-08-03 | 俄亥俄州创新基金会 | 与加快的体液亲和力相关的方法和组合物 |
WO2019035972A1 (en) * | 2017-08-16 | 2019-02-21 | Georgia State University Research Foundation, Inc. | SEQUENTIAL IMMUNIZATIONS WITH HIV-1 ENV VIRUS TYPE PARTICLES |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
US5614612A (en) * | 1990-03-09 | 1997-03-25 | Haigwood; Nancy L. | Purified gp120 compositions retaining natural conformation |
CA2164505A1 (en) * | 1993-06-07 | 1994-12-22 | Phillip W. Berman | Hiv envelope polypeptides |
US6818222B1 (en) * | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
DK1042001T3 (da) * | 1997-12-16 | 2002-07-08 | Chiron Corp | Anvendelse af mikropartikler kombineret med submikron-(olie-i-vand)-emulsioner |
EP1239876B1 (de) * | 1999-11-19 | 2008-07-30 | Csl Limited | Hcv-impfstoff zusammensetzungen |
-
2003
- 2003-01-14 US US10/501,606 patent/US20050175631A1/en not_active Abandoned
- 2003-01-14 WO PCT/US2003/001261 patent/WO2003059385A2/en active Application Filing
- 2003-01-14 ES ES03729676T patent/ES2339762T3/es not_active Expired - Lifetime
- 2003-01-14 AT AT03729676T patent/ATE458496T1/de active
- 2003-01-14 DK DK03729676.1T patent/DK1471936T3/da active
- 2003-01-14 DE DE60331412T patent/DE60331412D1/de not_active Expired - Lifetime
- 2003-01-14 CA CA002472579A patent/CA2472579A1/en not_active Abandoned
- 2003-01-14 EP EP03729676A patent/EP1471936B1/de not_active Expired - Lifetime
-
2008
- 2008-11-28 US US12/324,933 patent/US20090081254A1/en not_active Abandoned
-
2010
- 2010-11-08 US US12/941,176 patent/US20110045017A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE60331412D1 (de) | 2010-04-08 |
ES2339762T3 (es) | 2010-05-25 |
WO2003059385A3 (en) | 2003-08-21 |
DK1471936T3 (da) | 2010-04-26 |
EP1471936A2 (de) | 2004-11-03 |
EP1471936A4 (de) | 2006-10-25 |
US20090081254A1 (en) | 2009-03-26 |
CA2472579A1 (en) | 2003-07-24 |
WO2003059385A2 (en) | 2003-07-24 |
US20050175631A1 (en) | 2005-08-11 |
EP1471936B1 (de) | 2010-02-24 |
US20110045017A1 (en) | 2011-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
ATE426412T1 (de) | Adjuvante influenza-vakzine | |
IL202978A0 (en) | West nile virus vaccine | |
NO20015073D0 (no) | Vaksiner | |
WO2005116270A3 (en) | Influenza virus vaccine composition and method of use | |
MX2008013993A (es) | Combinación adyuvante sinergistica de anticuerpo agonista de cd40/interferona tipo 1, conjugados que la contienen y uso de los mismos como un terapeutico para aumentar la inmunidad celular. | |
WO2009072767A3 (en) | A powerful vaccine composition comprising a lipopeptide and poly i:c as an adjuvant | |
HUP0301180A2 (hu) | Imidazokinolinaminok adjuvánsként való használata DNS vakcinálásban | |
ATE499112T1 (de) | Immunologische verwendungen von immunmodulatorischen verbindungen für einen impfstoff und therapie gegen infektionskrankheiten | |
WO2006068663A3 (en) | Vaccine compositions for treating coronavirus infection | |
DE60012042D1 (de) | Entepneumovirus und entsprechendes impfstoff | |
HUP0500238A2 (hu) | Interleukin-12 alkalmazása állatgyógyászati vakcina adjuvánsként | |
WO2005028496A3 (en) | Vaccine for treatment and prevention of herpes simplex virus infection | |
IL182440A0 (en) | Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection | |
ATE460943T1 (de) | Therapeutische mittel als antikrebs impfstoffadjuvantien und deren therapeutische verfahren | |
WO2004026260A3 (en) | Prophylactic and therapeutic hiv aptamers | |
ATE420658T1 (de) | Imidazoquinolinamine als adjuvantien für hiv dna vakzine | |
BRPI0414073A (pt) | método para induzir uma resposta imune contra infecção por rotavìrus a partir de um sorotipo de rotavìrus, e, uso de uma cepa de rotavìrus atenuado de um sorotipo | |
MX2007002659A (es) | Composicion vacunal contra el virus de la hepatitis c. | |
WO2003032917A3 (en) | Hookworm vaccine | |
EA200700017A1 (ru) | Способ усиления иммунного ответа на вакцину | |
WO2005097179A3 (fr) | Antigene tat stabilise et ses applications pour la vaccination anti-vih. | |
AR027738A1 (es) | Composicion coadyuvante, composiciones de vacunas que incluyen dicha composicion coadyuvante; procedimiento de induccion de inmunorespuestas antigenicas enmamiferos y procedimiento de tratamiento donde se aplican dichas vacunas | |
DK1237571T3 (da) | Toscana-virus-nukleinprotein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1471936 Country of ref document: EP |